Table 2.
Systemic and Adipose Tissue Inflammation
| Genea | Placebo | P | Rifaximin | P | Treatment | ||
|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Difference P | |||
| Plasma cytokines | |||||||
| IL-6 (pg/mL) | 1.02 ± 0.15 | 1.25 ± 0.22 | 0.09 | 1.01 ± 0.42 | 0.97 ± 0.31 | 0.78 | 0.16 |
| TNF-α (pg/mL) | 2.61 ± 0.18 | 2.62 ± 0.17 | 0.95 | 2.97 ± 0.26 | 2.83 ± 0.24 | 0.04 | 0.44 |
| MCP1 (pg/mL) | 159 ± 12.6 | 147 ± 4.8 | 0.343 | 132 ± 11 | 128 ± 10.4 | 0.325 | 0.50 |
| Adipose tissue gene expression b | |||||||
| IL4 | 0.90 ± 0.07 | 1.09 ± 0.19 | 0.25 | 1.01 ± 0.1 | 1.28 ± 0.21 | 0.07c | 0.69 |
| IL6 | 0.52 ± 0.17 | 0.55 ± 0.09 | 0.84 | 0.91 ± 0.49 | 0.88 ± 0.52 | 0.70 | 0.70 |
| CCL5 | 0.60 ± 0.14 | 0.49 ± 0.02 | 0.44 | 1.04 ± 0.39 | 0.87 ± 0.36 | 0.40 | 0.83 |
| ADIPOQ | 1.04 ± 0.08 | 0.99 ± 0.09 | 0.67 | 0.94 ± 0.12 | 1.03 ± 0.11 | 0.50 | 0.42 |
| IL1B | 0.61 ± 0.16 | 0.82 ± 0.29 | 0.50 | 1.39 ± 0.48 | 0.94 ± 0.32 | 0.19 | 0.14 |
| IL10 | 1.06 ± 0.28 | 1.12 ± 0.45 | 0.83 | 1.16 ± 0.36 | 1.23 ± 0.25 | 0.82 | 0.98 |
| IL12B | 1.14 ± 0.43 | 2.22 ± 0.57 | 0.05 | 1.28 ± 0.36 | 0.72 ± 0.19 | 0.13 | 0.01 |
| TNF | 1.30 ± 0.13 | 1.46 ± 0.28 | 0.58 | 2.00 ± 0.25 | 1.67 ± 0.25 | 0.03 | 0.12 |
| CCL2 | 1.11 ± 0.22 | 1.34 ± 0.30 | 0.14 | 1.30 ± 0.27 | 1.34 ± 0.30 | 0.90 | 0.33 |
| CD68 | 1.12 ± 0.23 | 0.98 ± 0.28 | 0.47 | 1.16 ± 0.25 | 1.28 ± 0.18 | 0.43 | 0.28 |
Boldface numbers indicate P < 0.05.
Gene expression was measured in SC WAT by real-time RT-PCR. The expression levels were normalized to the geometric mean of six housekeeping genes and the data, expressed as arbitrary units, are means ± SEM.
NCBI gene symbol.
P < 0.1.